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ABSTRACT

Using magnetic resonance imaging, relaxation rate measurements were performed
in cancer cells overexpressing a magnetotactic bacterial gene, MagA. Measurements of
magnetic resonance relaxation rates in this expression system is important for optimizing cell
detection and specificity, for developing quantification methods, and for refinement of genebased iron contrast using magnetosome associated genes. We measured the total transverse
relaxation rate (R2*), its irreversible and reversible components (R2 and R2′, respectively)
and the longitudinal relaxation rate (R1) in MDA-MB-435 tumor cells. Clonal lines
overexpressing MagA were cultured in the presence and absence of iron supplementation,
and mounted in a spherical phantom for relaxation rate measurements at 3Tesla. In addition
to MR measures, cellular changes in iron were evaluated by inductively-coupled plasma
mass spectrometry. Values of R2* and R2ʹ were significantly higher (p < .01, accounting for
multiple comparisons) in iron-supplemented, MagA- expressing cells compared to
unsupplemented cells. R2* provided the greatest absolute difference and R2′ showed the
greatest relative difference, consistent with the notion that R2′ may be a more specific
indicator of iron-based contrast than R2, as has been observed in brain tissue. R2 differences
ii

between the supplemented and non-supplement MagA-expressing cells showed a trend
(p < .05) toward significance. R1 differences between these conditions were not significant.
For parental cells, no significant differences between iron-supplemented and unsupplemented
cells were observed in any of the relaxation rates. The results highlight the potential of
magnetotactic bacterial gene expression for detecting labeled cells.

Keywords: Magnetic resonance imaging, MagA, relaxation rates, iron, cancer cells
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Chapter 1
1.1

Molecular Imaging and Image-Based Cell Tracking
The further development of molecular imaging techniques, involving the

improvement and testing of unique tools and reagents as a means to detect molecular
pathways in vivo, is a current area of research which is growing rapidly [1-4]. This type of
imaging provides a non-invasive way of monitoring processes leading to disease, from
diagnosis through therapy. Molecular imaging can potentially enable one to monitor cellular
activity in terms of location, distribution and long term viability. Scientific accomplishments
have been obtained through various imaging systems, such as bioluminescence and
fluoresecence, computed tomography (CT), positron emission tomography (PET), single
photon emission computed tomography (SPECT), ultrasonography (US), magnetic resonance
spectroscopy (MRS) and magnetic resonance imaging (MRI). Each of these imaging
modalities has its own advantages and disadvantages.
Of the various imaging platforms, MRI, has distinguished itself as a promising
system. The strengths of MRI, the imaging modality used in this thesis, include the ability to
image at any tissue depth [5] and to provide excellent soft tissue contrast with high spatial
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resolution [6]. Since its introduction over 25 years ago, MRI has been applied to longitudinal
studies [7, 8] and the repetitive monitoring of processes like therapeutic stem cell
engraftment, cancer growth and metastasis, changes in pancreatic beta cell function during
diabetes and cardiac cell activity after heart attack [9]. In spite of these strengths, MRI fails
to track cellular and molecular activities as has been achieved in optical imaging using
reporter genes such as the green fluorescent protein and luciferase [2, 10]. While these
reporters may provide fine spatial and temporal information for cell microscopy, in vivo
optical imaging of live animals is limited to superficial regions because of the absorption and
scattering of light. Of the non-invasive in vivo imaging modalities, MRI has relatively high
spatial resolution and allows long-term repetitive imaging, without using ionizing radiation.
However, MRI fails to show high sensitivity compared to SPECT and bioluminescence
imaging. In order to take advantage of MRI in image-based cell tracking, labeling of cells is
required to improve bio-imaging at the cellular and molecular level [11].

1.2

Cell Tracking using MRI
Progressive molecular imaging techniques cater to advanced and improved ways for

quantitative cell tracking. In order to detect transplanted cells using MRI, cells need to be
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labeled with magnetic contrast agents. Initially most methods for tracking cells
involved the use of exogenous labels, such as superparamagnetic iron oxide (SPIO)
nanoparticles because of the high sensitivity of detecting these labeled cells [12, 13]. This
high sensitivity is due to the large amount of SPIO iron that can be taken up. For example,
single cell MRI detection has been accomplished in one study where the average iron content
per cell was approximately 70 pg [14]. Gene based methods have also been under
development to address one of the problems with SPIO nanoparticle labeling: dilution of the
particle following repeated cell divisions. Another shortcoming of SPIO particles concerns
their localization upon cell death. For example, macrophages engulf dead cells and may
release the iron in a spatially and temporally different pattern than the original host cell. As a
result of this, the free SPIO may remain in the body and show MR contrast which can be
misleading [15]. In a report by Amsalem et al. it was shown that MRI signal voids were not
from the SPIO labeled transplanted cells but instead from the cardiac macrophages which
took up the free SPIO [16]. Haacke et al. also showed that free SPIO released by dead cells
was taken up either by macrophages or nested in the local tissue [17]. To effectively monitor
cell location and activity it is essential to be able to specifically detect live cells. Various
methods of overcoming the limitations of cell tracking with exogenous cell labeling have
3

been adapted including the use of endogenous or gene-based labels.

1.3

MRI using Gene-Based Label
To circumvent the problems associated with cell tracking using SPIO nanoparticles,

described above, genetic engineering methods have been employed to overexpress genes
involved in the transport and storage of iron thereby leading to an increase in the intracellular
level of iron [9]. Various methods and proteins dealing with iron have been studied for their
proficiency as MR contrast agents, along with those recognized for their primary function in
mammalian iron homeostasis: iron response elements [18], transferrin receptor [19] and
ferritin subunits [20]. Part of the challenge in adapting iron binding proteins for use in
generating MR contrast relates to the elaborate control of iron homeostasis in mammalian
cells [21] and the manner in which this may fluctuate in response to changes in physiological
state [22]. The development of these gene-based contrast agents for MRI leads to the
possibility of imaging reporter gene expression and pathology in transgenic animals [23].
Although the evolution of gene-based, MR contrast for cell tracking and the MRI
methodology used for its detection is progressing it requires further development.
Research in the last decade has revealed that iron biomineral formation is a
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phenomenon that can occur naturally in the animal kingdom. Magnetotactic bacteria are an
extraordinary example of how single cells may synthesize and compartmentalize an iron
biomineral, magnetite (Fe3O4), in a membrane-enclosed magnetosome [24-26] and harness
its magnetic properties [27]. Although an understanding of the molecular nature of the
magnetosome is not yet complete, many applications making use of its effect on the MRI
signal have been carried out [28, 29]. A more complete understanding of which genes are
essential for the synthesis of the basic magnetosome compartment and for the manipulation
of select magnetosome features, would permit the versatile use of this structure in the
generation of MR contrast for pre/clinical imaging [9].
Several genes involved in the formation of magnetosome and magnetotactic bacteria
have been studied. Among these genes, MagA, was one of the first to be identified and has
been partially characterized as an iron transport protein [30]. MagA, an integral membrane
protein, is potentially involved in the active transport of the large quantity of iron required
to support magnetosome formation [31]. As expected, MagA-expression results in iron
accumulation in the cell [32]. As a result, this leads to a change in contrast detectable by MRI
[33, 34]. Additionally, the estimated iron per cell using this gene-based contrast is close to
0.6 pg/cell [34] and is approximately 100 x lower than the SPIO values provided earlier [14].
5

There are some advantages and disadvantages of using cells manipulated to
overexpress MagA. These advantages are (i) Longitudinal imaging over time can be
performed – ideally no dilution of the label occurs with cell division if it is assumed that iron
levels in extracellular fluid are sufficiently high. Keeping these iron levels high enough may
require iron supplementation of drinking water for animals. (ii) Working with MagA may
lead to the development of a reporter gene, i.e., a gene construct capable of monitoring
transcription factor activity. Disadvantages of MagA (or other gene-based iron labeling)
include the lower sensitivity due to lower iron uptake (approximately 100 times lower
compared to SPIO particles) and the complexity of cell preparation.
Recently, contrast due to overexpression of either MagA or the modified ferritin
subunits (heavy and light chain, HF + LF), lacking iron response elements to enable
continuous expression, were compared in a model of tumour growth from transplanted cells
[35]. These studies suggest that magnetotactic bacterial genes, including magnetosome
genes, may be effectively used in the future for reporter gene expression for molecular MRI.

1.4

Role of MagA in MRI
Cells with iron-based contrast agents are difficult to differentiate from

anatomical features represented as dark regions on MRI because hypointense signals are
6

generated when these contrast agents are used [36]. In this scenario, MagA overexpression
may be particularly useful in tracking breast cancer metastasis in the white matter of brain
[37]. Recently, a group characterized the temporal pattern of contrast due to the constitutive
expression of MagA [35] to utilize this technique in future for reporter gene expression in
tumor xenografts.
Previous measurements of MRI relaxation times in MagA-expressing mammalian
cells have been carried out. Manipulation of T2 relaxation time (refer to section 1.5.2) for
cell detection was assessed in 293FT cells using doxycycline induced expression of MagA,
cloned from M. magnetotacticum strain MS-1[33]. The effect of varying concentrations of
iron supplement on T2 relaxation rate was examined on a 3T MR scanner using a CarrPurcell-Meiboom-Gill (CPMG) sequence. The relaxation rate of MagA-expressing cells
showed that the measurement of R2 (1/T2) depended on the concentration of iron (ferric
nitrate) in the culture medium. In this study by Zurkiya et al., they showed that induction of
MagA-expression (by doxycycline) was coordinated with the increase in R2. This not only
shows that a molecular interaction can stimulate changes in R2 through a genetic mechanism
but also provides strong support for the application of gene-based iron contrast. In this cell
line expressing MagA, values of R2 varied roughly between 6-9 s-1.
7

In 2011, another magnetotactic bacterial gene, Mms6, was reviewed as an MRI
reporter [38]. This small protein associated with Mms6 gene, acidic in nature and showing
high affinity for iron ions [39], was used in 293T cells for investigating the same R2
relaxation rates [40]. The response pattern of the R2 relaxation rate to the iron-supplemented
Mms6-expressing cells was similar to that of the MagA-expressing cells, but R2 was lower in
value (4-6 s-1) in the identical cell line. Although Mms6 has a potential as a reporter gene,
further work is required to demonstrate its efficiency in producing MR contrast.
In another assessment of MR intracellular contrast, MagA cloned from strain AMB-1
was compared to a mutated form [33]. Mouse neuroblastoma (N2A) cells were transfected
with MagA, mutant or vector DNA, cultured in the presence of 250 μM ferric nitrate and
immobilized in gelatin phantoms for imaging at 11T. Based on the image analysis the authors
reported that MagA-expressing cells can produce signal contrast over mutant or vector
controls detectable by MRI. In this same report, the potential of MagA- expressing cancer
cells to grow and generate intracellular contrast in vivo was evaluated on a 3T MRI system.
Human MDA-MB-435 cells were transfected with MagA and transplanted subcutaneously
into the hind limb of immune-deficient mice. The results of this imaging study not only
revealed that tumours formed from MagA-expressing cells generated hypointense signal
8

regions compared to the parental control but also showed that MagA-expression maintained
the biological programming of cancer cells.
Recently, it has also been shown that MR contrast can be observed when the
overexpression of MagA from AMB-1was compared to that of modified, mammalian ferritin
subunits [35]. In a mouse model of tumor growth, transplanted cells were imaged over 5
weeks in a repetitive manner and compared to the parental cell xenograft. Both MagA- and
HF+LF-expressing tumors provided contrast enhancement. Moreover, MagA-derived
contrast exhibited greater contrast to noise ratio than HF+LF-expressing tumors, particularly
in the immediate days post-injection, indicating a role for select magnetotactic bacterial
genes in preclinical molecular imaging.
Despite the fact that very little is recognized regarding the handling of MagA activity
in mammalian cells and whether or not MagA activity can be coordinated with precise
location of its contrast signal, quantitative measures of iron contrast, such as relaxation rates
(see section 1.6), can be of great value in localizing iron-loaded cells in the developing
tumor. Relaxation rates provide an objective means for quantifying our observations. Also,
such measures may in the future be utilized in developing methods for estimating the number
of cells in each voxel.
9

Before discussing the specific MRI measures used in this thesis, some of the basic
principles of MRI will be briefly presented. Since MRI involves creating images of nuclear
magnetic resonance (NMR) signals, MRI will be discussed after describing the basics of
NMR.

1.5

Nuclear Magnetic Resonance
1.5.1 Basics of NMR
The nature of NMR is based on the interactions of nuclear spins with an external

magnetic field. In the classical view, protons are spinning charged particles producing a
small magnetic moment [41]. They possess spin, a fundamental property of nature. Protons
are fermions or spin ½ particles. They have spin angular momentum, ⃗, which is associated
with a magnetic diploe moment, ⃗ that is oriented along the spin axis and expressed as
⃗⃗ =  ⃗⃗

(1.1)

where , known as the gyromagnetic ratio, is a nuclei specific constant. For protons
(/2) = 42.576 × 106 Hertz per Tesla (Hz/T) [41].
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Figure 1.1. Proton spin and its relation to magnetic moment
Magnetic resonance imaging is based on detecting NMR signals from hydrogen
nuclei (single proton), which are the most abundant nuclei present in the body [41]. In
particular it is hydrogen in water (or fat) that gives rise to most of these signals.
The sum of all nuclear magnetic moments in a given volume is known as the nuclear
magnetization ( ⃗⃗⃗ ). In the context of MRI, ⃗⃗⃗ usually refers specifically to the nuclear
magnetization from protons in water (or fat). (Signals from hydrogen nuclei in
macromolecules, cell membranes etc. typically decay away too quickly to observe with
conventional MRI.) In the absence of an external magnetic field, the net magnetization is
zero. This is because all the spins are randomly oriented and as a result their magnetic
moments cancel out. If a large external magnetic field (⃗⃗⃗⃗⃗) is present, the nuclear
11

magnetic moments partially align with it. Some of the spins align with their z-component
parallel to ⃗⃗⃗⃗⃗ while others align antiparallel to ⃗⃗⃗⃗⃗. However, there are slightly more spins
aligned parallel than antiparallel (difference on the order of 1 in 106) to the direction of B0
giving rise to the net magnetization (M) along this direction (z-direction).
In the classical picture, the spins’ magnetic moments precess (clockwise) around the
direction of the external magnetic field at a frequency

, known as the resonance or

Larmor frequency, determined by
(1.2)
Since the x, y components of these magnetic moments cancel, the total magnetization,
⃗⃗⃗⃗⃗⃗ is in the direction of ⃗⃗⃗⃗⃗, [42]. This is known as the “equilibrium state” of the
magnetization (Figure 1.2).

Figure 1.2. Magnetization in equilibrium state. ⃗⃗⃗⃗⃗⃗⃗ is parallel to the external magnetic
field ⃗⃗⃗⃗⃗⃗ and is in equilibrium along the field
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In order to produce an NMR signal the magnetization must be forced away from
equilibrium. In the classical description when a torque is applied to the magnetization M0, it
tips away from its initial position (Figure 1.3), parallel to the axis of B0 or z-axis. This
rotation is accomplished using a time-dependent magnetic field known as a radiofrequency
pulse (RF pulse), B1.

Figure 1.3. Magnetization in a non-equilibrium state. ⃗⃗⃗⃗⃗⃗⃗ is tipped away from the z-axis
by an RF pulse

The tilted magnetization can be decomposed into two orthogonal components: a
longitudinal or Z component and a transverse component on the XY plane (Figure 1.4).

13

Figure 1.4. Orthogonal components of the magnetization vector
Radiofrequency (RF) pulses create a time-varying magnetic field ⃗⃗⃗⃗⃗⃗, perpendicular
to ⃗⃗⃗⃗⃗ , oscillating at the Larmor frequency (or close to it). RF pulses can rotate the
magnetization through any angle. In the case of a 90° RF pulse, the net magnetization is
rotated into the x, y plane. As the magnetization is tipped away from the z-axis it begins to
rotate about this axis at the Larmor frequency and this continues following the pulse. The
rotating magnetization (magnetic field) induces a voltage signal in a nearby radiofrequency
coil (antenna).
As soon as the RF pulse ceases, the system or the excited proton spins return from the
unstable state to an equilibrium state. This return of the magnetization to its equilibrium
position is termed “Relaxation”. There are two components to relaxation: the decay of Mxy
14

and the return of Mz to its equilibrium state.

1.5.2 Transverse Relaxation
The return of Mxy to equilibrium or zero value is called transverse relaxation. This
decay is in some cases, an exponential decay process and is characterized by a time constant
known as T2* or the transverse relaxation time or as a rate R2*(1/T2*). This decay is due to
dephasing of the magnetic moments. For example, when a proton spin feels a strong local
magnetic field in the direction of B0 it will precess faster than average while a proton spin
that feels a local magnetic field in the direction opposite to B0 will precess slower than
average and these magnetic moments will get out of phase leading to overall signal decay.
There are various sources of transverse magnetization decay including nuclear spin-spin
interactions and local magnetic field variations over distance scales from microscopic to
macroscopic. For example iron particles create spatially non-uniform magnetic fields ranging
over micron or tens of micron distance scales, intermediate between dipolar magnetic fields
(angstroms to nanometers) and the macroscopic magnetic field variations (mm to cm).
During the transverse magnetization decay a second RF pulse that rotates the
magnetization though 180° can be applied and will have the effect of partially reversing the

15

dephasing described above. Thus there are reversible and irreversible contributions to R2*.
In this thesis we will denote the irreversible and reversible components as R2 (1/T2) and R2ʹ
(1/T2ʹ ) respectively, where
R2* = R2 + R2ʹ

(1.3)

Some authors define R2 as being only due to the nuclear spin-spin interactions. However,
other sources of microscopic magnetic field variation, such as that due to iron particles can
lead to partially irreversible transverse magnetization decay due to the effects of water self
diffusion. (Some authors would consider this diffusion effect as an “apparent” contribution to
R2.) In particular, a water molecule will likely be in a different location during the
dephasing are rephrasing periods (before and after the 180°, respectively), and hence, the
dephasing will not be completely rephased. Cellular iron influences both R2 and R2ʹ with
the degree of reversibility depending on spatial distribution of particles.
Nuclear spin-spin relaxation is governed by the interactions between proton spins and
their surroundings. In general, each of the proton spins creates a non-uniform local magnetic
field distributed roughly over molecular distance scales. As a result a given nucleus can
experience widely varied local magnetic field values based on the location and orientation of
its neighbours.
16

In solids, where the local field distribution is almost static, the T2 decay times are
on the order of microseconds. In liquids, due to rapid motion of the water molecules, the
local magnetic field experienced by each proton changes rapidly thereby reducing effect of
the local magnetic fields leading to longer decay times, on the order of milliseconds.

1.5.3. Longitudinal Relaxation
The regrowth of Mz along z-axis takes place through longitudinal or spin-lattice
relaxation, characterized by a time constant T1 or the longitudinal relaxation time.
Transitions of excited proton spins to the equilibrium position are due to the local
magnetic fields experienced by a single nucleus (1H for water) from its neighbouring nuclei
(1H) including neighbor on the same water molecule as well as the nuclei (1H) of nearby
water molecules. This local magnetic field fluctuates rapidly because of the rapid motion of
the water molecules. The fluctuations are typically spread out over the spectrum from low to
very high, much higher than the Larmor frequency (the correlation time for water is roughly
on the order of 10-12 sec). It is the frequency component at the Larmor frequency that leads
to T1 relaxation.

17

1.5.4. Nuclear Magnetic Resonance Signals
The free induction decay (FID) is the signal obtained following a single RF pulse.
The decay of this signal corresponds to the T2* decay of the magnetization described above.
The amplitude of this generated signal decays to zero, without losing energy to the
environment. In tissues the FID typically has a duration of tens of millisecond.
A spin echo sequence uses a 90° RF pulse followed by a 180° RF pulse. The 90°
pulse is applied to tip the total magnetization M0 into the transverse or XY plane where the
spins dephase naturally. Then after a certain time period a 180° pulse is applied in order to
partially refocus (only the static part) of the dephased spins. The spins at this point maintain
the same precessional frequencies with reversed phase angles. The time period between the
90° and 180° RF pulses is represented by TE/2 which is half of the echo time (TE). After a
certain time, equal to the delay between 90° and 180° pulse, the spins partially rephase
forming an echo (Figure 1.5).
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Figure 1.5. Spin echo pulse sequence. 180° RF pulse following a 90° RF pulse refocuses
the spins to create the echo of the signal called the spin echo (SE) at the echo time (TE).

1.6

Magnetic Resonance Imaging (MRI)
Magnetic resonance imaging (MRI) signals are similar to NMR signals but

MRI also involves localization of this signal which is accomplished with magnetic field
gradients. There are three field gradients, one in each of the three directions, x, y and z.
The magnetic field gradient refers to an additional magnetic field that varies linearly in one
of the directions (typically the gradient or slope has a maximum value on the order of tens of
mT/m).
MRI pulse sequences are comprised of RF pulses and gradient magnetic fields.
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The order, amplitudes, shapes, and spacing of both RF and gradient waveforms are included
in each pulse sequence. Here we will consider conventional spin-echo (SE) and
gradient-echo (GE) pulse sequences as these are relevant to the experiments carried
out for this thesis.

1.6.1 Spin-Echo Imaging
In conventional spin echo imaging (Figure 1.6) the RF pulses are similar to those in
nuclear magnetic resonance (NMR) except that they are slice selective in the case of twodimensional (2D) acquisitions. RF pulses combine with a gradient to generate a rotation
angle typically between 0° and 90° for protons that are located within a slice of tissue
(typically a few mm thick). Localization within the plane of the image is accomplished by
frequency encoding in one direction and phase-encoding in the orthogonal direction. The
frequency encoding gradient when applied in one direction creates linear variation of
precession frequencies along that direction which encodes the positions of the resonating
spins based on the frequency of their signals. The phase encoding gradient, is utilized to
impart a specific phase angle to the transverse magnetization. This angle depends on the area
under the phase encoding gradient lobe and the position of the spins along the phase
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encoding direction. Phase encoding is accomplished by repeating the signal acquisition (Ny
times, see Figure 1.6) while incrementing the area under the phase encoding lobe each time.
The spatial information is encoded in the phase of the signals. In acquiring a SE image the
segment shown in Figure 1.6 is repeated Ny times, where Ny, is the number of phase
encoding steps (equal to the matrix size of the image in the phase encoding direction). The
time between each of these segments is called the repetition time TR.

Figure 1.6. Pulse sequence diagram for conventional spin-echo imaging.

The amplitude of a simple spin-echo signal, in the limit where TR >> TE, is given by the
following equation:
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(

)

(

)

(1.4)

However, a closer approximation is given by replacing TR by TR – TE, given by [43]
(

)

(

)

(

)

(1.5)

1.6.2 Gradient-Echo Imaging
The GE sequence is simpler than SE sequence and uses a single RF pulse followed by
a gradient pulse to generate the echo. The scan times for GE sequences can be much shorter
than for SE sequences because short TR times can be used if small flip angles are employed
for excitation. In GE sequences, gradient reversal is used to form the gradient echo [45, 46]
instead of the 180° refocusing pulse, used for echo formation in the SE sequence. Gradient
reversal is applied with the frequency encoding gradient and hence this gradient performs the
function of echo formation and spatial encoding along one dimension. The amplitude of the
single gradient-echo signal (Figure 1.7) is similar to the FID signal assumed to be
exponential, given by
(

)

(

22

)

(

)

(1.6)

Figure 1.7. Simple single gradient echo pulse sequence. Excitation pulse is followed by a
gradient pulse which makes the spins to rephase and form a gradient echo.

The multi-echo gradient echo sequence is similar to the single-echo gradient echo
sequence except that in this case signals at multiple TE’s are acquired within each TR period.

1.6.3 Inversion Recovery Spin-echo Imaging
The inversion recovery spin-echo sequence, is applied in my thesis for the
measurement of R1 (1/T1). The pulse sequence is similar to that of the spin-echo, except that
an additional 180° RF pulse is included prior to the 90° RF pulse. This initial 180° pulse
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inverts the z-magnetization and hence is referred to as an inversion pulse. The time delay
between the inversion pulse and the 90° pulse is known as the inversion time (TI).
The inversion recovery spin-echo signal is given by
(

1.7

)

(

)

(

)

(

)

(1.7)

Thesis Overview
There is a great deal of interest in developing magnetic resonance imaging (MRI)

methods to monitor the location of cancer cells as well as their molecular activity in animal
models of tumor growth and metastasis. Labeling cancer cells with iron nanoparticles
provides a means of detection and localization. Iron particles create a microscopically nonuniform magnetic field, which in turn, influences fundamental MRI parameters called
relaxation rates.
The most common method of iron-based cell labeling involves the introduction of
exogenous superparamagnetic iron oxide nanoparticles. Although this provides high
sensitivity for cell detection, the potential for long-term monitoring is limited due to
degradation, dilution of the label during cell division and lack of inherent biological activity.
Alternatively, gene-based contrast imparts endogenous magnetic characteristics to cells, thus,
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creating a tracking system suitable for long-term, repetitive imaging of cellular function,
including migration, mitosis and differentiation. In mammalian cancer cells, Goldhawk et al.
[33] and Zurkiya et al. [34] have previously demonstrated that expression of MagA, a
putative iron transport protein from magnetotactic bacteria, leads to observable alterations in
the MR signal.
The goal of my work was to quantify the effect of MagA -based iron labeling on
MRI relaxation rates in order to provide insight into designing methods in the future for
tracking these cells in-vivo. As mentioned earlier, both R2 and R2* are influenced by iron
and other tissue properties. However, studies related to R2ʹ measurements in tissues showed
that R2ʹ was more characteristic of iron content than R2 [47]. Hence, the work in this thesis
also includes assessing R2ʹ as a measure for detecting these labelled cells. My hypothesis is
that R2ʹ will provide a stronger indicator to detect iron supplementation in MagA
samples and will correlate more strongly with iron content as compared to other relaxation
rates. The experiments are carried out using MDA-MB-435 cells, a highly metastatic and
aggressive cell line that was genetically engineered to overexpress MagA, in order to
generate gene-based contrast.
In Chapter 2, an imaging design, involving quantification of the MRI signal
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changes associated with cellular iron uptake by MagA-expressing cells has been applied
to track gene-based iron-labeled cells. This quantification is based on measuring the MRI
relaxation rates (R2*, R2, R2ʹ and R1) in cultured MagA-expressing cells and in the
untransfected parental cell line (MDA-MB-435), as a control. Using 3 Tesla (T) MRI and
gelatin phantoms, my thesis demonstrates how the relaxation rates vary as a function of iron
supplementation. Results are also examined in light of elemental iron content to reflect the
degree of iron uptake.
In Chapter 3, the findings in chapter 2 are highlighted to address the efficiency of a
single magnetotactic bacterial gene as an MR contrast agent, subject to genetic control. A
summary of the findings along with future directions of this research are also provided.
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Chapter 2
2 Relaxation Rate Measurements in MagA-expressing Cancer
Cells
For the work presented in this chapter I would like to acknowledge Kimberley Lam
Tin Cheung and Sarah Donnelly for their contribution in performing BCA protein assays,
the Laboratory for Geochemical Analysis within the Department of Earth Sciences at
Western for performing iron analysis and Dr. Donna Goldhawk for her coordination in the
analysis of cellular iron. All other procedures including cell phantom preparation, MR
acquisition, data analysis and statistical analysis were performed by Anindita Sengupta.

2.1

Introduction
This chapter presents an investigation of the transverse (R2*, R2 and R2') and

longitudinal (R1) relaxation rates in MagA-expressing MDA-MB-435 cells measured with
3 Tesla (T) MRI. These measurements provide quantitative information on the influence of
the iron label on the MRI signals. In addition, elemental iron content measurements are
presented and related to the MRI results. The findings highlight the utility of a single
magnetotactic bacterial gene as an MR contrast agent. The potential for further
improvements in MR detection of gene-based contrast upon a more complete representation
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of the magnetosome compartment is predicted.

2.2

Methods
2.2.1 Cell Culture
The cell lines used for these experiments consisted of human MDA-MB-435 in the

form of a clonal population previously transfected with MagA and stably expressing this
gene[1]. Cells were kept in culture for approximately 3 months.
Cells were cultured in low glucose Dulbecco’s Modified Eagle Medium
supplemented with 10% fetal bovine serum and 0.5% penicillin/streptomycin. Ironsupplemented cells were prepared by incubation with medium containing 250 μM ferric
nitrate (Sigma-Aldrich, Oakville, Canada) for at least 5 days. All cell culture reagents were
purchased from Life Technologies (Burlington, Canada) unless otherwise noted.
Each cell type was grown as a monolayer on 100mm-plates. Stable expression of a
MagA clone from pcDNA3.1Zeo(+) was obtained with 800 μg/ml Zeocin. The cultures were
incubated at 37°C until the cells reached 90-100% confluency at which time they were
amplified onto 150mm-culture dishes. At harvest, cells were washed 3 times with
phosphate-buffered saline pH 7.4 (PBS) , a physiological salt solution containing NaCl, KCl,
Na2HPO4 and KH2PO4 in concentrations of 137, 2.7, 10 and 2 mmol/L respectively, to
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remove medium and the extracellular iron supplement. All cell types were harvested from
150 mm plates into centrifuge tubes by gentle trituration and were subjected to three cycles
of centrifugation at 400xg (where “g” stands for relative centrifugal force) for 5 min at 15˚C
during the PBS washes. Cells were then counted using a hemacytometer.

2.2.2 Phantom Preparation
Approximately 50-60 million cells of each type were placed in the wells from a 96well break-apart plate (Nunc, Rochester, U.S.A.). Each well of inner diameter 6 mm and
height 10 mm was centrifuged at 400 × g and for 5 min. to form a compact pellet
approximately 6 mm in height. Cell pellets were overlaid with 1% gelatin/PBS and
embedded in one hemisphere of a 9cm spherical phantom filled with 4% gelatin/PBS. A
spherical-shaped phantom was used to minimize macroscopic magnetic field
inhomogeneities which would interfere with accurate R2' measurement. Samples
consisted of either parental or MagA-expressing cells, cultured in the presence and
absence of iron supplementation. To form the spherical gelatin phantom, the empty
hemisphere was filled with 2% gelatin/PBS and placed on top of the half containing cell
samples. To avoid susceptibility artifacts at the interface, air was excluded using a layer of
parafilm. Figure 2.1 illustrates the phantom set-up used for relaxation rate measurements.
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Figure 2.1 Cell Phantom for relaxation rate measurement

2.2.3 Relaxation Rate Measurements
Phantoms were scanned on a 3T Biograph mMR (Siemens AG, Erlangen,
Germany) equipped with an actively shielded whole-body gradient system (with maximum
gradient strength and slew rate of 45mT/m and 200T/m/s, respectively). A 15-channel knee
coil was used for radiofrequency (RF) excitation and signal reception.
Image-based measurements of relaxation rates (R1, R2, R2*) were performed using
the sequences and parameters provided in Table 1.
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Table 1. Sequences and parameters used for measuring relaxation rates.

Relaxation
Rates
R2

Sequence

Singleecho

TE

TR

(ms)

(ms)

13-300

TI (ms)

Matrix

Flip
Angle

*

1000

˗

192 × 192

90°

1000

˗

192 × 192

60°

(9 TE values)
Spin-echo
R2*

Multi-echo

6.12-80

Gradientecho

(9 echoes)

Inversion13
4000
22-3900
128 × 128
90°
recovery
(6 values)
spin-echo
*Note: For the single spin-echo sequence rather than fixing TR, the value of TR-TE was
R1

fixed ( [2] and equation (1.5)).
The slice thickness was 1.5 mm and the field of view (FOV) was 120 mm for all the images.
Voxel dimensions were 1.5×0.6×0.6 mm for R2 and R2* acquisitions and 1.5×0.9×0.9 mm
for R1 acquisitions.
MRI data were collected from 11 experiments where each experiment includes cell
harvest, phantom preparation and the MRI scan. Typically the phantom for each experiment
included four separate samples (i.e. each in a nunc well). In two experiments all cell
samples, from each of the four groups [ parental(P), iron-supplemented parental (P+Fe),
MagA-expressing (MagA) and iron-supplemented MagA-expressing (MagA+Fe)] were
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imaged together. Whereas the phantom contained only MagA+Fe and MagA-Fe samples for
six of the experiments and it contained only P+Fe and P-Fe for three experiments.
Image processing and analysis were performed using commercial software tools.
With the aid of MATLAB 7.9.0 (R2010b) a region of interest (ROI) was selected in each
well to include the maximum number of voxels (approx. 30-50), excluding ones adjacent to
the wall of the well. R2, R2*and R1 were determined with least square curve fitting (Sigma
Plot 10.0.inc) of the mean ROI signals using equations 1.5, 1.6 and 1.7 in Chapter 1 as
appropriate where the absolute value of equation 1.7 was used. R2' was obtained by
subtraction (R2*-R2) (refer to equation 1.3 in Chapter 1).

2.2.4 Protein and Trace Element Analysis
Samples were sent to the Analytical Services Laboratory of Surface Science
Western at Western University (London, Canada) for trace element analysis of iron and zinc
using inductively-coupled plasma mass spectrometry (ICP-MS). To prepare samples for trace
element analysis and protein quantification, cells were cultured as described above for MRI
experiments and were harvested based on the confluency of 150mm-culture dishes a day or
two before or after the actual day of MRI scan. Cells were then lysed in
radioimmunoprecipitation assay (RIPA) buffer/protease inhibitor cocktail, such that
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approximately 10 million cells were solubilized per ml of lysis solution. The total
protein from lysis of these cultured cells was quantified using the bicinchoninic acid assay
(BCA assay) [3]. Zinc provided a measure of cellular redox status as well as a point of
comparison to amount of iron. Iron content was then normalized to quantity of protein as
determined by the BCA assay . Over the course of relaxation rate measurements, iron content
was periodically evaluated in cultured cells.

2.2.5 Statistical Analysis
Relaxation rate means, standard deviations (SD) and standard errors of the mean
(SEM) were calculated for all group values. We then compared each cell type (parental and
MagA), group mean relaxation rates (R2*, R2, and R2') between runs, with versus without
iron supplementation, using the independent sample t-test. We performed analysis of
variance (ANOVA) on the absolute difference values obtained by subtracting mean
relaxation rate values from the respective rank values between groups based on cell type and
iron supplementation. The result showed no significant difference between the mean values.
This was done to test the homogeneity of variance for our non-parametric data. The nonparametric Kruskal-Wallis test was then used to compare all runs of relaxation rates with iron
versus all runs without iron, combining data from both cell types. Since there is no

37

accepted method for determining the statistical interaction between two variables with a nonparametric test a parametric analysis was also performed. (It is the interaction between iron
condition (iron supplemented vs unsupplemented) and cell type (parental vs MagA) that is of
most importance in this study). The parametric test, Two-way ANOVA was run to obtain the
main effects and the interaction between the variables. All tests were two-tailed and SPSS
version 20.0 was the statistical package used. Considering the effects of multiple
comparisons, p < .01 was considered as significant. This was based on having 6 comparisons
and rounding off the value 0.05/6 to 0.01. Although there are 4 parameters (R2, R2ʹ, R2* and
R1) only 3 are independent (R2, R2ʹ and R2* have only 2 independent parameters) so there
are really only 3x2 = 6 comparisons rather than 4x2 = 8 comparisons.

2.3

Results
2.3.1 Relaxation Rates
Representative spin-echo images of the phantom showing wells containing

parental and MagA-expressing cells are illustrated in Figure 2.2A. Part B of this figure
displays the unnormalized signal decay curves with respect to TE for iron-supplemented
MagA-expressing and parental samples. The symbols represent the mean signal intensities
within regions of interest including most of the voxels in each well as described under
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methods. Figure 2.2B shows faster signal decay for iron-supplemented MagAexpressing cells when compared to the iron-supplemented parental cells.

Figure 2.2 Signal decay curves. Representative data indicate the influence of echo time
(TE) on signal decay. (A) Single-echo spin echo (SE) images show sample wells in cross
section at 3 different TE values (13, 100 and 300 ms): 1, parental (P); 2, MagA (A); 3, ironsupplemented MagA (A+Fe); 4, iron-supplemented parental (P+Fe); and 5 polystyrene
marker for reference. Samples along the bottom row are combinations of MagA-expressing
and parental cells. (B) R2 relaxation curves are shown for iron-supplemented samples.
Symbols indicate the mean signal intensity within a ROI at each TE. Best fit points are joined
by splines to represent an exponential decay.

As expected, R2* representing the total transverse relaxation rate (comprised of the
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reversible component R2ʹ and the irreversible component R2), shows higher decay rate of
signal intensities than its components (Figure 2.3).

Figure 2.3 Comparison between (a) R2* and (b) R2 relaxation curves for parental and
MagA-expressing cell samples. The R2 relaxation curve is the same as Figure 2.2(B),
except that it only includes the first 80 ms of the decay for comparison with the R2* curve
(a). The R2* curves show a greater difference between the MagA-expressing and parental
cells.

Figure 2.3, demonstrates that R2* shows a stronger difference between MagA+Fe and
Parental+Fe than does R2.
Transverse relaxation rates, R2, R2* and R2ʹ, all were notably different in
iron-supplemented cells overexpressing MagA. For each relaxation rate, significant main
effects for the iron condition were found with both two-way ANOVA and Kruskal-Wallis
tests (Figure 2.4). More importantly, the ANOVA provided a significant interaction between
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iron condition and “cell type”, more specifically between iron-supplemented vs.
unsupplemented and MagA-expressing vs. parental.
The independent sample t-test showed that there was no significant difference in
MR relaxation rates for iron-supplemented and unsupplemented parental cells. However, a
statistically significant influence of iron-supplementation existed for R2* (p < .01) and R2ʹ
(p < .001) in cells overexpressing MagA as shown in Figure 2.4. For R2 the influence of iron
supplementation showed only a trend (p < .05) when accounting for multiple comparisons.
R2* provided the greatest absolute difference in MR relaxation rates and R2' displayed the
greatest relative difference. The significant effect of iron supplementation was found also by
the non-parametric Mann-Whitney test.
.
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Figure 2.4. Transverse and longitudinal relaxation rates. Bar graphs indicate the change
in all 3 transverse relaxation rates and the lack of change in longitudinal relaxation rate upon
iron supplementation of parental and MagA-expressing cells. R2* showed the greatest
absolute difference between iron supplemented vs. unsupplemented cells, while R2' showed
the greatest relative difference between these cell groups. R1 is similar for all parental (n=2)
and MagA-expressing (n=5) cell samples. Error bars represent SEM. The number of samples
for parental+Fe, parental-Fe, MagA+Fe, MagA-Fe were 5, 5. 8 and 8 respectively for
transverse measurements and 2, 2, 5 and 5 for longitudinal relaxation rate measurents.
 for p < .001,  for p < .01 and  for p < .05 (trend).

The bar chart in Figure 2.4 shows the mean values of the transverse and
longitudinal relaxation rates of parental and MagA-expressing cell samples both ironsupplemented and unsupplemented. Significant differences are observed between R2*
(p < .01) and R2ʹ (p < .001) for iron-supplemented MagA-expressing cells.
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Figure 2.5 illustrates a scatter plot of the individual transverse relaxation rates for
each group. This scatter plot is presented in addition to the bar graph in Figure 2.4 (means
and SEMs) in order to more completely show the variability of measurements. Although the
transverse relaxation rates for iron-supplemented MagA-expressing cells were significantly
higher than for unsupplemented MagA-expressing samples, there is nevertheless substantial
variability in measurements especially when iron-supplemented.
For all cell types and culture conditions, R1 remained virtually constant between
0.72- 0.81 s-1 and was not pursued as an indicator of cellular iron contrast. The scatter plots
for R1 are not shown because variability was low for R1.
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Figure 2.5. Scatter plot showing transverse relaxation rates for parental and MagAexpressing cell samples both iron-supplemented and unsupplemented. This plot was
included to illustrate the relatively large degree of variability in these rates especially for
iron-supplemented MagA-expressing cells.

2.3.2 Trace Element Measurements
In MagA-expressing cells, cultured in the absence of iron supplementation, ICP-MS
analysis indicated 0.047 ± 0.006 μg Fe/mg protein (n=7; mean ± SEM) and 0.249 ± 0.047 μg
Zn/mg protein. In contrast, the presence of iron supplementation in MagA-expressing cells
increased iron content to approximately 0.755 ± 0.157 μg/mg protein while level of zinc
stayed at approximately 0.135 ± 0.023 μg /mg protein (Table 2). Additional data for the ratio
of iron/zinc in non-supplemented cultures showed lower values compared to the
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supplemented ones. Samples both in presence and absence of iron when evaluated using a
student’s t test showed significance at p < .01 for iron, but not significant for zinc.
Table 2. Trace element analysis^ of cells cultured in the presence or absence of iron
supplementation.*

Sample

Iron#

Zinc#

Fe/Zn

N

P

0.250

0.117

2.14

1

P+Fe

0.475

0.107

4.44

1

MagA

0.047 ± 0.006

0.249 ± 0.047

0.19

7

MagA+Fe

0.755 ± 0.157

0.135 ± 0.023

5.60

7

^ Data were collected using either ICP-MS.
* Cells were incubated in the presence (+Fe) or absence of 250 μM ferric nitrate
Elemental analysis is reported as μg/mg protein; mean ± SEM in case of MagA-expressing
samples only.
#

Figure 2.6 illustrates a plot of the transverse relaxation rates R2*, R2 and R2ʹ vs iron
content, for iron supplemented and unsupplemented MagA-expressing cell samples.
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Figure 2.6. Relaxation rates (A) R2*, (B) R2 and (C) R2ʹ vs iron content for MagAexpressing cell samples. All the graphs showed correlation of relaxation rates with iron
content (μg per mg of protein) in MagA-expressing cell samples both iron-supplemented and
unsupplemented (empty diamonds = MagA and filled diamonds = MagA+Fe).
As shown in Figure 2.6, a significant correlation ( p < .005) between R2ʹ and iron
content (normalized to protein content) was observed.

2.4

Discussion
The results of this study may help to design and optimize methods for tracking

gene-based iron-labeled cells in vivo. Relaxation rate measurements, a quantitative approach
to assess iron-related contrast, may be helpful to track iron-loaded cells more precisely in the
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developing tumor. As advances in MR hardware, sequences and contrast agents [4] progress,
so too will molecular MRI. In this study, to approach that goal, measurements of relaxation
rates were performed to explore the potential for contrast enhancement in cancer cells
utilizing overexpression of MagA, a bacterial gene.
Using phantoms of compact cell pellets, we quantified cellular MR contrast using
relaxation rate measurements. Longitudinal relaxation rates were influenced very little, if
any, by the cellular iron and this is consistent with the literature [5]. On the other hand,
transverse relaxation rates were strongly affected by iron supplementation for
MagA-expressing cells (Figure 2.4). For this cell type the elemental iron content was also
higher in supplemented versus unsupplemented samples.
Every cell maintains their normal redox states which when disturbed, toxic effects
like oxidative stress occur, damaging components of cells. Changes in cellular zinc levels
provide one indicator of oxidative stress [6]. In our analyses, we showed specific iron uptake
and relatively constant levels of zinc in iron-supplemented MagA-expressing cells, consistent
with little or no redox cytotoxicity.
In this study, the relaxation rates and iron levels for MagA-expressing cells
investigated in presence of iron-supplementation demonstrated the potential for taking up
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iron, leading to MRI contrast. This quantitative result was consistent with a previous study
where the potential of MagA-expression to produce intracellular contrast in mouse
neuroblastoma (N2A) cells was studied [1]. As well, the iron-related contribution to
transverse relaxation increases with field strength, thus, contrast differences between gene
expression and controls should be greater at higher fields.
R2 measurements have previously been reported in 293FT cells expressing MagA
(approx. 20 s-1, 3 T, n=4) [7]. The values for MagA-expressing cells compare well
with the findings in this thesis; however, my results (Figure 2.4) indicated that R2 alone
provides the weakest index of MR contrast activity based on student’s unpaired t-test.
Measures of R2* and R2' were found to provide the most statistically significant changes in
cellular contrast upon iron supplementation. In addition, relative changes in R2' were larger
than those in R2, suggesting the potential of R2' for better iron-related specificity, as
previously suggested for human brain regions with high iron [2]. This may be important for
in vivo cell tracking and optimization of molecular MRI.
In our study, the constitutive expression of MagA in MDA-MB-435 cells was
unhampered by protein tags and previously confirmed to provide high levels of MagA
mRNA expression relative to β-actin using reverse transcription polymerase chain reaction
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(RT-PCR). The constitutive expression of fusion protein, enhanced green fluorescent protein
(EGFP)-MagA, has been confirmed in both mouse neuroblastoma N2A cells [1] and in
MDA-MB-435 cells (unpublished results). Using the MTT assay, it has also been shown that
the proliferation of transfected tumor cells is not altered by the activities of MagA expression
[1]. In our study we detected the activity of MagA using relaxation rate measurements. In
addition, iron uptake in MagA-expressing cells was greatly influenced by the presence of an
iron supplement (250 μM ferric nitrate).
In a mouse xenograft model of tumor growth, Rohani et al. [8] showed that MagA
expression generated a peak in MR contrast in vivo during the second week of tumor growth,
similar to the contrast derived from the expression of modified ferritin subunits lacking iron
response elements to enable continuous expression. Beyond 3 weeks post-injection, MR
contrast in the parental tumor also increased, reducing the benefit of contrast gene expression
in larger tumors. To improve image analysis, relaxation rate measurements using optimal
measures provides an additional tool for assessing MagA-derived MR contrast and could be
implemented for a longitudinal study as that by Rohani et. al.[8].
Gene-based contrast like MagA overexpression may be helpful in tracking
metastasis in the white matter of brain for breast cancer [9]. When a gene-based iron contrast
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responds clearly to iron supplementation, it becomes suitable for revealing changes in iron
homeostasis. As an example, in a study by Shpyleva et al., they reported changes in the level
of ferritin subunits between epithelial and mesenchymal breast tumor cell lines [10]. In that
study MagA overexpression might be a preferred tool to track cells in order to avoid
interference with the cell biology related to cancer.
The finding of this work that relaxation rates for MagA-expressing cells can be
distinguished from parental controls is encouraging, however for in vivo detection the
challenge will be to distinguish MagA-expressing cells from surrounding tissue. In vivo there
is an additional challenge of distinguishing MagA-expressing iron labeled cells from
endogenous iron, where the level of endogenous iron will depend on the particular organ to
be imaged. For in vivo image acquisition, relaxation rate measurements will encounter
further limitations. Background field inhomogeneities due to susceptibility differences
between tissues will always contribute to R2* measurements unless correction procedures are
applied [11]. Furthermore, the measurement of R2 would require long acquisition times.
Although transverse relaxation rates vary as a function of tissue iron [12],
R2 in particular is affected by other factors in the tissue or cell, such as water content
reflecting proton density, subcellular compartmentalization and water-protein interactions.
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By comparison, R2' is mostly influenced by sources of magnetic field inhomogeneity. If
sources of macroscopic inhomogeneity are minimized, as done here by using a spherical
phantom, then R2' should be influenced mostly by microscopic sources of inhomogeneity,
which in our samples should be from iron particles. In order to correct for macroscopic
inhomogeneities in-vivo, post processing methods have been developed [11]. This involves
the use of the phase of the gradient echo signals, for which no added acquisition is required.
In a study on small animal imaging this same idea was adapted where R2* and R2ʹ
measurements from superparamagnetic iron nanoparticles labeled cancer cells were reported
[11].
The results reflected in Figure 2.6, supported the notion that transverse relaxation
rates are strongly influenced by the amount of iron [2]. Among all the transverse relaxation
rates, R2ʹ showed the strongest correlation with the amount of iron for MagA-expressing
cells. This suggests the potential of R2' for better iron-related specificity for imaging of
gene-based iron-labeled cells and is consistent with, the effect of iron in human brain regions
with high iron [2].
From our iron level measurements expressed as μg Fe/mg protein we can estimate
the amount of iron per cell in our samples. Our nunc wells had approximately 60 × 106 cells
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in a volume of π(3mm)2 (6 mm) ≈ 170 μL, and this corresponds to 3 × 10-9 g/cell assuming a
density of 1.0 g/ml. If we also assume that approximately 20% of the mass of a cell is protein
then each cell has approximately 6 × 10-7 mg protein/cell. Therefore our highest iron level for
MagA+Fe (≈1.4 μg Fe/mg protein) corresponds to approximately 0.84 pg Fe/cell which is
similar to the levels reported by Zurkiya et al [7] (≈0.6 μg Fe/cell) and almost 100 times
smaller than reported for SPIO loading [13]. The number of cells in each MRI voxel
can be estimated from the number of cells/volume (60 × 106 /170 μL) and the volume of each
voxel (≈0.5 μL) leading to an estimate of ~ 2 ×105 cells/ voxel. In a separate report [20] we
demonstrated voxel-by-voxel mapping of these relaxation rates indicating that we can easily
detect 2 ×105 cells with this setup. However our phantom included approximately 400g of gel
which acted as a large source of noise. If we were imaging a mouse brain for example (~10 g)
inside a small RF coil we would have greatly increased signal-to-noise and could detect
perhaps ~ 104 cells and perhaps as low as 103 cells especially at higher field strength and with
more optimized acquisitions.
The principle iron import mechanism in mammals, via the transferrin receptor, is
universally expressed in almost all cells [14], with increased levels of transferrin expression
in cells that are propagating rapidly and require iron in order to function [15]. Tumor cells
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when compared to healthy tissue have low levels of ferritin expression with high levels of
transferrin receptor[16, 17]. These changes related to iron uptake regulation, storage and
distribution support rapid cell proliferation, for example by supplying iron as a cofactor for
ribonucleotide reductase and DNA synthesis [18, 19]. The propensity of proliferating cells
toward iron uptake may be used to best advantage in cancer cell tracking by MRI and the
development of gene-based contrast. In a related study from my work, a drop in transferrin
receptor was detected in parental (data not shown) as well as engineered cells following
culture in the presence of iron supplementation [20]. Therefore, the activity of MagA has
elicited the same homeostatic response as expected of an increase in ferritin storage. In spite
of this, a statistically significant level of MR contrast enhancement was achieved suggesting
that MagA may function outside the regulatory control of iron binding proteins. In the case of
MagA activity, the lack of cellular regulation may be reflected in greater fluctuation in iron
levels and therefore in MR contrast. This in turn may result in a relatively large degree of
variability in the transverse relaxation rates of the iron-supplemented MagA-expressing cells
(Figure 2.5). The ability of MagA to circumvent key features of mammalian iron regulation,
without causing cytotoxicity, will bode well for future development of gene-based contrast.
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Chapter 3
Summary and Future work
3.1

Summary of Findings
In summary, we have used the MagA gene from magnetotactic bacteria to impart

magnetic sensitivity to mammalian cancer cells and provide groundwork for cell tracking by
MRI. Our study reported the use of transverse relaxation rate measurements as an effective
tool for quantifying the contrast enhancement previously reported [1] in MDA-MB-435 cells
overexpressing MagA, under iron supplemented conditions. Although transverse relaxation
rate measurements revealed an increased value for iron-supplemented MagA-expressing cells
compared to its unsupplemented and parental controls, longitudinal relaxation rates failed to
discriminate between these cell types regardless of the level of extracellular iron. Also R2ʹ
quantification of MagA-expressing iron-labeled cells showed a potential to be more
characteristic of iron, consistent with previous studies of tissue and suggesting that R2ʹ has
better iron-related specificity than other relaxation rates [2].
Our results also suggested a relatively large degree of variability in both transverse
relaxation rate and the intracellular iron content of MagA-expressing cells cultured in the
presence of iron supplementation. Further work to determine the sources of variability will
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increase the potential of R2ʹ as an indicator of MagA-derived contrast and may provide genebased contrast for MRI which in future may help to detect cell growth and differentiation
more effectively in vivo.

3.2

Future Work
Chapter 2 establishes a method of detecting gene-based iron-labeled cells in-vitro

through quantifying the MRI signal changes associated with cellular iron uptake by MagAexpressing cells. A natural extension of this work would be its implementation for celltracking in-vivo such as in the case of a mouse model of tumour growth from transplanted
cells [1]. Previously reported methods [3] for correcting R2ʹ for “macroscopic” magnetic
field inhomogeneities within tumor tissue, where the iron-related contributions to R2ʹ are
expected to be minimal can be implemented and tested in the absence of iron
supplementation. There are some challenges related to R2 and R2ʹ measurements in vivo with
R2 requiring long acquisition times unless a multi-echo acquisition is used and R2ʹ being
influenced mostly by magnetic field inhomogeneties that can be corrected with the use of the
phase of the gradient echo signals. Also, relaxation mapping reported recently [4] using
optimal measures provides an additional tool for improving image analysis. R2 and R2ʹ these
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measurements can also be performed in mice bearing subcutaneous tumors on the hind limb
expressing MagA. In that case parental tumors on the opposite flank may provide
physiologically-relevant controls. Based on the results of this thesis, it can be hypothesized
that both R2 and R2ʹ values will be higher in MagA-expressing tumors than in controls, and
that the relative differences between MagA-expressing and parental cells will be higher for
R2ʹ.
This study can be extended for repetitive imaging of tumor growth and metastasis
in small animal model, with the goal of tracking changes in relaxation rates longitudinally
with time. In this instance, utilization of a MagA construct tagged with the hemagglutinin
(HA) epitope and commercial antibodies, will be suitable to correlate regions within the
tumor exhibiting MR contrast with localization of HA-MagA-expressing cells. The potential
of a dietary iron supplement for improving tumor cell contrast can also be examined.
In this particular thesis all the MR measurements were done at 3T. Previous studies
showed that R2 ′ in tissue increased with field strength [2] , suggesting that stronger R2 ′
differences between MagA and parental or other cells or tissues will be found at higher
fields. Thus for implementation of relaxation measurements for in-vivo tracking may be
better at higher fields.
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In mammalian cells, effective MR contrast derived from the overexpression of
iron handling protein(s) would benefit from a better understanding of which combination of
magnetotactic bacterial genes will (1) sequester iron within a membrane-enclosed vesicle and
(2) allow biomineralization of iron in the presence of mammalian iron homeostasis.
Magnetosome gene knock-out studies [5] suggests the probability that a subset of genes may
be used to generate a minimal compartment in multiple cell types that would permit iron
biomineralization for non-invasive medical imaging with MRI.
Is it possible for magnetosome-like particles to be reproduced in mammalian cells
in a safe and efficient manner for biomedical molecular imaging? Further research on
magnetotactic bacteria will provide critical information upon which this question may be
judged. Taking current knowledge into consideration, magnetosome-like vesicles in
eukaryotic cells should a) be composed of a lipid bilayer that interacts with cytoskeletal
protein to impart stability, b) be exposed to cytoplasmic or extracellular precursors for
biomineralization, c) impart magnetic properties to the cell, and d) be non-essential for cell
survival. The strict regulation of iron in vivo is advantageous in several ways, permitting
genetic manipulation of its localization, crystallization and association with key cellular
processes. We need additional information regarding prokaryotic iron binding proteins
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that can be genetically engineered to handle iron in a eukaryotic environment. We also need
to understand more about magnetic particles in mammalian and vertebrate systems.
The manner in which magnetite is dismantled during cell turnover or when magnetosomelike reporter gene expression is turned off will be important to understand for effective
measurement of cell tracking and of cellular activity. In principle, regulation of crystal size
and shape should influence MRI. However, recreating magnetism whereby cells move in a
magnetic field is not necessarily the goal of MR contrast. For medical imaging, we may not
need to form the same single magnetic domain that magnetotactic bacteria require for
magnetotaxis. This function requires larger magnetite crystals, approximately 50-100 nm in
length and their alignment along the magnetosome filament [6]. Crystal sizes that induce
superparamagnetic properties are approximately 30 nm in length and suitable for MRI and
altering proton spins. While an elaborate set of reactions and protein-protein interactions
contributes to the formation of uniform magnetite crystals, some redundancy in the protein
architecture of magnetosomes raises the possibility that a more basic set of magnetosome
genes might be sufficient for iron biomineralization and compartmentalization within a lipid
vesicle. Understanding the role of each magnetosome gene will foster future pre/clinical
applications in MRI.
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Development of these non-invasive cellular imaging methods is relevant to the study
of cancer progression. Preclinical models of aggressively growing cancers may be assessed
sooner in their development with respect to size or the change in cellular activity using
MagA overexpression as a tool. In future, this could potentially be applied to small animal
MRI to examine MagA reporter gene expression in developing tumor.
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ORAL:
1. Sengupta, A., Rohani, R., Thompson, R.T., Prato, F.S., Goldhawk, D., &
N. Gelman. MRI Relaxation Rates in Tumor Cells Expressing MagA
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PROFESSIONAL ASSOCIATION
12/11 – Present
International Society for Magnetic Resonance in Medicine
(ISMRM)
13/02 – Present
World Molecular Imaging Society (WMIS)
TECHNICAL SKILLS
Computer: MS Office, Matlab, C++
Laboratory: Cell Culture Techniques
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1. Basic Animal Care and Use Course (including sterile injections techniques
and basic handling, mouse injections and
techniques, mouse anesthesia and
assessment monitoring and intervention)
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3. Workplace Hazardous Materials Information System (WHMIS) for laboratory
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LANGUAGES
English, Bengali and Hindi – fluent in speaking, reading and writing

66

